Browse All
Displaying 486 - 490 of 2078
Author:Bermel, Robert Killestein, Joep Berger, Thomas Brochet, Bruno Carroll, William Freedman, Mark Holmoy, Trygve Karabudak, Rana Nos, Carlos Patti, Francesco Perrin Ross, Amy Vanopdenbosch, Ludo Vollmer, Timothy Buffels, Regine Kadner, Karen Bortolami, Oscar Hartung, Hans-Peter
Session Name:P7: MS Therapeutics 1
Topic:MS and Inflammatory Disease
Program Number:P7.003
Author Institution:Mellen Center for MS, Department of Neurology, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands, Amsterdam, Netherlands Department of Neurology, Medical University of Vienna, Vienna, Austria, Vienna, Austria University of Bordeaux, Bordeaux, France, Bordeaux, France Department of Neurology, Sir Charles Gairdner Hospital, Perron Institute for Neurological and Translational Science, The University of Western Australia, Nedlands, Australia, Subiaco, Australia University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, Ottawa, ON, Canada Department of Neurology, Akershus University Hospital, Lørenskog, Norway, Lasker, Norway Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey, Ankara, Turkey Centre d’Esclerosi Mútiple de Catalunya (Cemcat), Vall d’Hebron Hospital Universitari, Barcelona, Spain, Barcelona, Spain Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Neuroscience Section and Multiple Sclerosis Centre, University of Catania PO Policlinico G Rodolico, Catania, Italy, Catania, Italy Loyola University Chicago, Chicago, IL, USA , Oak Brook, IL Department of Neurology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium, Brugge, Belgium Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA, Aurora, CO F. Hoffmann-La Roche Ltd, Basel, Switzerland, Toulon, France F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland Department of Neurology, UKD, Centre of Neurology and Neuropsychiatry and LVR-Klinikum, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, Dusseldorf, Germany
Author:Williams, Mitzi Airas, Laura Chitnis, Tanuja Saini, Sarbjit Hide, Michihiro Sussman, Gordon Nakahara, Jin Bermel, Robert Dörner, Thomas Loop, Brett Ziehn, Marina Willi, Roman Kieseier, Bernd C. Nikolaev, Ivan Haemmerle, Sibylle Zharkov, Artem Siegel, Richard Cenni, Bruno Wiendl, Heinz Maurer, Marcus Giménez-Arnau, Ana Montalban, Xavier
Program Number:P7.015
Author Institution:Joi Life Wellness Group, Atlanta, GA, USA, Atlanta, GA Turku University Hospital and University, Finland, Turku, Finland Brigham and Women's Hospital, Department of Neurology, Boston, MA, USA, Boston, MA Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA, Baltimore, MD Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, Hiroshima, Japan University of Toronto, Toronto, Ontario, Canada, Toronto, ON, Canada Department of Neurology, Keio University School of Medicine, Tokyo, Japan, Shinjuku-ku, Japan Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Department of Rheumatology and Clinical Immunology, Charite Universitätsmedizin Berlin DRFZ, Berlin, Germany, Berlin, Germany Novartis Pharmaceutical Corporation, Cambridge, MA, USA, Cambridge, MA Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Novartis Pharma AG, Basel, Switzerland Department of Neurology, Heinrich-Heine University, Duesseldorf, Germany, Duesseldorf, Germany Novartis Institutes for Biomedical Research, Basel, Switzerland, Basel, Switzerland Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany, Muenster, Germany Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany, Berlin, Germany Department of Dermatology, Hospital del Mar - IMIM, Universitat Pompeu Fabra, Barcelona, Spain, Barcelona, Spain Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain
Author:Nakamura, Kunio Husak, Scott Bermel, Robert Cohen, Jeffrey Ontaneda, Daniel
Session Name:P10: MS Neuroimaging 1
Program Number:P10.011
Author Institution:Cleveland Clinic, Cleveland, OH
Author:Abbatemarco, Justin Ontaneda, Daniel Rensel, Mary Conway, Devon McGinley, Marisa Bermel, Robert Husak, Scott Bruckman, David Schold, Jesse Rose, Deja Miller, Deborah
Session Name:P13: MS Clinical Assessments and Outcome Measures
Program Number:P13.017
Author Institution:Cleveland Clinic , Cleveland, OH Cleveland Clinic, Cleveland, OH University of Colorado, Denver, CO Emory University, Atlanta, GA Cleveland Clinic Foundation, Cleveland, OH
Author:Moss, Jonah Schmid, Elizabeth Bermeo Ovalle, Adriana Stoub, Travis O'Dwyer, Rebecca
Session Name:P6: Behavioral and Cognitive Neurology: Neuroimaging studies in Cognitive and Behavioral Neurology
Topic:Behavioral and Cognitive Neurology
Program Number:P6.007
Author Institution:Rush University Medical Center, Chicago, IL Dominican University, River Forest, IL